The chemistry of confidence: Eurofins BPT and your onshoring strategy

Brandon Scanlon, Sr. Vice President, Southwest, Eurofins BioPharma Product Testing

The onshoring imperative

The BioPharma industry is experiencing a significant shift toward onshoring manufacturing operations. Driven by supply chain resilience, regulatory alignment, and strategic investment, this trend is reshaping where and how products are developed and tested. For companies starting up new facilities, speed and reliability are critical—and Eurofins BioPharma Product Testing (BPT) is uniquely positioned to help clients succeed during this transformation.

Eurofins BPT advantage: A network built for scale

Eurofins BPT offers an unmatched footprint designed to meet clients where they are. With 15 facilities across North America, more than 2,300 employees, and over 800,000 ft² of laboratory space, our network is built for flexibility and speed. Our hub-and-spoke model ensures proximity for work that benefits from co-location. Key analytical testing hubs include:

• East: Lancaster, PA, and Research Triangle Park, NC
• Midwest: Columbia, MO, and Portage, MI
• West Coast: San Diego, CA, (significant expansion underway)

Beyond these hubs, we maintain operations in Jacksonville, FL; Crown Point, IN; and San Francisco, CA; with regional services in Houston, TX, and Cambridge, MA, – all locations aligned with emerging manufacturing clusters.

Eurofins BPT’s NA footprint enables unparalleled regional coverage, flexibility, and responsiveness.

Solving client challenges: Speed, collaboration, and risk mitigation

Onshoring brings opportunity—but also challenges. Many clients tell us they lack resources to validate equipment, onboard staff, and maintain testing operations while focusing on manufacturing readiness. Talent shortages and time constraints only amplify these concerns.

Eurofins BPT solves these problems by:

• Accelerating timelines: Our proximity means faster turnaround and real-time collaboration. Co-location drives collaboration.
• Reducing risk: A distributed network with harmonized equipment, harmonized IT tools, and standardized processes ensure redundancy and continuity.
• Freeing client resources: We handle critical testing so clients can concentrate on getting new manufacturing sites operational.

Proven trust: partner with industry leaders

Our track record speaks for itself: 48 of the Top 50 Pharma Companies with a U.S. manufacturing presence already work with Eurofins BPT. This trust reflects our ability to deliver quality, compliance, and scalability at every stage of the product lifecycle.

Ready to support your onshoring journey

As BioPharma companies make bold investments in U.S. manufacturing, Eurofins BPT stands ready to help you succeed.

To find out more about how we can support your onshoring strategies, contact your Eurofins representative or: Contact Us to submit an inquiry.